|
|
Correction Correction: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancerGordon C Wishart1,7 1 Cambridge Breast Unit, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK 2 Strangeways Research Laboratory, Department of Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK 3 Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA 4 Eastern Cancer Registration and Information Centre (ECRIC), Unit C, Magog Court, Shelford Bottom, Hinton Way, Cambridge CB22 3AD, UK 5 West Midlands Cancer Intelligence Unit, Public Health Building, The University of Birmingham, Birmingham, B15 2TT, UK 6 Department of Oncology, University of Cambridge, and Functional Breast Cancer Genomics Laboratory, Cancer Research UK Cambridge Research Institute, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK 7 National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK
Breast Cancer Research 2010, 12:401doi:10.1186/bcr2480 See related research by Wishhart et al., http://breast-cancer-research.com/content/12/1/R1 The electronic version of this article is the complete one and can be found online at: http://breast-cancer-research.com/content/12/2/401
© 2010 BioMed Central Ltd CorrectionFollowing the publication of our article [1] we noticed an error in Table 1 relating to the number of patients who received adjuvant therapy. The correct table is given here (Table 1). Table 1. Patient characteristics for model development (ECRIC) and validation (WMCIU) cohorts References
Have something to say? Post a comment on this article! |
|
|
|
 |  | Log on/register BioMed Central home | Journals A-Z | Feedback | Support | My details |
home | issues | articles | reports | supplements | weblinks | conferences | search | information | subscribe | my details |
on Google Scholar
author email
corresponding author email|
|
| © 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media. |